EAGLE PHARMS INC (EGRX) Free Cash Flow by Year
EAGLE PHARMS INC generated $50.5M in free cash flow in fiscal year 2022. This represents an increase of 81.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2022 through Q2 FY2023, the same line adds up to an outflow of $9.4M in free cash flow. The table below carries 11 fiscal years, from 2012 to 2022, and the quarters EAGLE PHARMS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EGRX Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
EGRX Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More EAGLE PHARMS INC financials
Frequently Asked Questions
What was EAGLE PHARMS INC's free cash flow in fiscal year 2022?
EAGLE PHARMS INC generated $50.5M in free cash flow in fiscal year 2022.
How fast is EAGLE PHARMS INC's free cash flow growing?
EAGLE PHARMS INC (EGRX) free cash flow rose by 81.1% year over year, from $27.9M to $50.5M in fiscal year 2022.
What is EAGLE PHARMS INC's free cash flow over the last twelve months?
EAGLE PHARMS INC (EGRX) reported an outflow of $9.4M in free cash flow over the trailing 12 months, Q3 FY2022 through Q2 FY2023, summed from the four most recent quarterly filings.
How has EAGLE PHARMS INC's free cash flow changed over the years?
Across the 11 fiscal years this page covers, EAGLE PHARMS INC (EGRX) free cash flow went from -$15.6M in fiscal year 2012 to $50.5M in fiscal year 2022.
What was EAGLE PHARMS INC's free cash flow in the most recent quarter?
EAGLE PHARMS INC (EGRX) reported -$132K in free cash flow in Q2 2023. This represents a decrease of 100.3% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what EAGLE PHARMS INC (EGRX) reported on that line in every period on record.